ValiRx PLC Director/PDMR Shareholding (5433V)

TIDMVAL

RNS Number : 5433V

ValiRx PLC

07 August 2020

VALIRX PLC

("ValiRx", the "Company" or the "Group")

Director Dealing

London, UK 7 August 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company announces the following dealing in the ordinary shares of the Company made by a Director.

On 7 August 2020, the Company was informed that Dr Kevin Cox, Non-executive Chairman of the Company, acquired 117,000 ValiRx ordinary shares at an average price of 8.2 pence per share on 7 August 2020, representing approximately 0.22% of the Company's issued ordinary share capital. Following this acquisition, Dr Cox now holds an interest in 250,333 ValiRx ordinary shares, representing approximately 0.46% of the Company's issued ordinary share capital.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information please contact:

 
 ValiRx plc                                           Tel: [phone] 
                                                                       2628 
                                                             www.valirx.com 
  Suzanne Dilly                                    [e-mail] 
 
   Cairn Financial Advisers LLP(Nominated              Tel: [phone] 
   Adviser)                                                            0880 
   Liam Murray / Jo Turner / Ludovico Lazzaretti 
 
   Peterhouse Capital Limited (Sole Broker)            Tel: [phone] 
   Duncan Vasey / Lucy Williams / Eran Zucker                          0930 
 
 
 
 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
------  -------------------------------------------------------------------------------- 
 a.      Name                                       Dr Kevin Cox 
                                                   ------------------------------------- 
 2       Reason for notification 
        -----------------------------------------  ------------------------------------- 
 a.      Position/Status                            Non-executive Chairman 
        -----------------------------------------  ------------------------------------- 
 b.      Initial notification/                      Initial 
          Amendment 
        -----------------------------------------  ------------------------------------- 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
        -------------------------------------------------------------------------------- 
 a.      Name                                       ValiRx PLC 
        ----------------------------------------- 
 b.      LEI                                           213800VQKB9SJCQDET40 
        -----------------------------------------  ------------------------------------- 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
------  -------------------------------------------------------------------------------- 
 a.      Description of                             Ordinary Shares 
          the financial 
          instrument, type 
          of instrument                              ISIN: GB00BLH13C52 
 
          Identification 
          Code 
        -----------------------------------------  ------------------------------------- 
 b.      Nature of the                              On market Purchase 
          transaction 
        -----------------------------------------  ------------------------------------- 
 
 c.      Price(s) and volume(s)                      Price(s)          Volume(s) 
        -----------------------------------------   ---------------- 
    8.2 pence                                                          117,000 
   -----------------------------------------------------------------  -------------- 
 
 d.      Aggregated information 
          - Aggregated Volume                         N/A 
          - Price 
        -----------------------------------------  ------------------------------------- 
 e.      Date of the transaction                    07/08/2020 
        -----------------------------------------  ------------------------------------- 
 f.      Place of the transaction                   London, UK 
        -----------------------------------------  ------------------------------------- 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBXGDIIBGDGGR

(END) Dow Jones Newswires

August 07, 2020 09:20 ET (13:20 GMT)